ADCT
ADCT
CH0499880968
ADC Therapeutics SA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 81.357.000 70.837.000
14.9%
Cost of Revenue 5.798.000 5.949.000
2.5%
Gross Profit 75.559.000 64.888.000
16.4%
182.766.000 194.479.000
6.0%
Operating Income -107.207.000 -129.591.000
17.3%
Pretax Income -141.608.000 -156.136.000
9.3%
Net Income Common Stockholders -142.623.000 -157.846.000
9.6%
-- --
--
-- --
--
ende